THE UTILIZATION OF DIOSGENIN FOR MANAGING THE GENETICALLY TRANSMITTED OPTIC NERVE SHEATH MENINGIOMAS (ONSMS). JRA. 2024;6(1). Accessed December 22, 2024. https://journlra.org/index.php/jra/article/view/1427